Persistence and adherence to dutasteride/tamsulosin fixed-dose versus free-combination alpha blocker...
Persistence and adherence to dutasteride/tamsulosin fixed-dose versus free-combination alpha blocker/5ARI therapy in patients with benign prostate hyperplasia in Germany
About this item
Full title
Author / Creator
Publisher
Germany: Dustri - Verlag Dr. Karl Feistle GmbH & Co. KG
Journal title
Language
English
Formats
Publication information
Publisher
Germany: Dustri - Verlag Dr. Karl Feistle GmbH & Co. KG
Subjects
More information
Scope and Contents
Contents
To evaluate real-world persistence and adherence in patients with benign prostate hyperplasia (BPH) receiving a fixed-dose combination of dutasteride plus tamsulosin (DUT-TAM FDC) versus α-blocker plus 5-α reductase inhibitor (AB/5ARI) free-combination therapy.
This retrospective, observational cohort study utilized the German IMS LRx (IQVIA) da...
Alternative Titles
Full title
Persistence and adherence to dutasteride/tamsulosin fixed-dose versus free-combination alpha blocker/5ARI therapy in patients with benign prostate hyperplasia in Germany
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6921277
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6921277
Other Identifiers
ISSN
0946-1965
DOI
10.5414/CP203549
